Australian Technical Advisory Group on Immunisation (ATAGI) Statement

on the administration of seasonal influenza vaccines in 2026

ATAGI download dated 27/2/2026

  • Influenza virus strains included in the 2026 Southern Hemisphere seasonal influenza vaccines:

  • A/Missouri/11/2025 (H1N1)pdm09-like virus

  • A/Sydney/1359/2024 (H3N2)-like virus

  • B/Austria/1359417/2021 (B/Victoria lineage)-like virus

Highlights for changes to 2026 influenza vaccine formulations and dosing

  • The registration age for adjuvanted influenza vaccine (Fluad®) has been extended to people aged 50 years and above. Fluad is NIP funded for people aged 65 years and above. People 50 to 64 years of age can access this through the private market.

  • All influenza vaccines available in Australia in 2026 are trivalent (i.e. containing two A strains and one B lineage). The B Yamagata lineage virus is no longer included in influenza vaccines as it may be extinct.